Plunging Colonoscopy Rates May Signal Crisis Ahead (Medscape)
“We’ve made 32% fewer colon cancer diagnoses by mid-April compared with last year at that time.” Conversation with Jennifer A. Christie, MD; Carol A. Burke, MD and Klaus Mergener, MD, PhD.
Treating Colorectal Cancer in the COVID-19 Era (Medscape)
“Our QUASAR group validated the Oncotype DX for colon cancer. The problem is that the risk factors associated with this assay for colon cancer are not as strong as for breast cancer.”
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.